German biotech boom: Innovations at what risk? | Made in Germany | DW | 21.09.2021

Visit the new DW website

Take a look at the beta version of dw.com. We're not done yet! Your opinion can help us make it better.

  1. Inhalt
  2. Navigation
  3. Weitere Inhalte
  4. Metanavigation
  5. Suche
  6. Choose from 30 Languages

Made in Germany

German biotech boom: Innovations at what risk?

BioNTech's success in developing a COVID-19 vaccine drew global attention to the German biotech scene — but this alone doesn't finance research. Does Germany stand in the way of its own biotech innovation?

Watch video 04:53